Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial

被引:39
|
作者
Wanlapakorn, Nasamon [1 ,2 ]
Maertens, Kirsten [3 ]
Vongpunsawad, Sompong [1 ]
Puenpa, Jiratchaya [1 ]
Thao Mai Phuong Tran [4 ]
Hens, Niel [4 ,5 ]
Van Damme, Pierre [3 ]
Thiriard, Anais [6 ]
Raze, Dominique [6 ]
Locht, Camille [6 ]
Poovorawan, Yong [1 ]
Leuridan, Elke [3 ]
机构
[1] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand
[2] Chulalongkorn Univ, Div Acad Affairs, Fac Med, Bangkok, Thailand
[3] Univ Antwerp, Fac Med & Hlth Sci, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Univ Pl 1, B-2610 Antwerp, Belgium
[4] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium
[5] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, Antwerp, Belgium
[6] Univ Lille, Ctr Hosp Reg Univ Lille, CNRS,Inst Pasteur Lille, Ctr Infect & Immun Lille,U1019 UMR8204,INSERM, Lille, France
基金
欧洲研究理事会;
关键词
pertussis; pregnancy; maternal immunization; humoral immune response; functionality; PRIMARY IMMUNIZATION; IMMUNE-RESPONSES; IMMUNOGENICITY; TDAP; IMPACT; WOMEN;
D O I
10.1093/cid/ciz778
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The blunting effect of pertussis immunization during pregnancy on infant antibody responses induced by whole-cell pertussis (wP) vaccination is not well-defined. Methods. This randomized controlled trial (NCT02408926) followed term infants born to mothers vaccinated with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine during pregnancy in Thailand. Infants received either acellular pertussis (aP)- or wP-containing vaccine at 2, 4, 6, and 18 months of age. A comparison group comprised wP-vaccinated children born to mothers not vaccinated during pregnancy. Antibodies against pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN) were evaluated using commercial enzyme-linked immunosorbent assays. Functionality of antibodies against Bordetella pertussis was measured using Bordetella pertussis growth inhibition assay. Results. After maternal Tdap vaccination, 158 infants vaccinated with aP-containing vaccines possessed higher antibody levels (P < .001) against all tested B. pertussis antigens postpriming compared to 157 infants receiving wP-containing vaccines. At 1 month postbooster, only anti-FHA and anti-PRN antibodies were still significantly higher (P < .001) in the aP group. Significantly higher anti-PT and anti-FHA (P < .001), but not anti-PRN immunoglobulin G, were observed among 69 wP-vaccinated infants born to control mothers compared with wP-vaccinated infants of Tdap-vaccinated mothers after primary and booster vaccination. The antibody functionality was higher in all wP-vaccinated infants at all times. Conclusions. Maternal Tdap vaccination inhibited more pertussis-specific responses in wP-vaccinated infants compared to aP-vaccinated infants, and the control group of unvaccinated women had highest PT-specific responses, persisting until after the booster dose. Antibody functionality was better in the wP groups.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 50 条
  • [31] Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine
    Olin, P
    Rasmussen, F
    Gustafsson, L
    Hallander, HO
    Heijbel, H
    LANCET, 1997, 350 (9091): : 1569 - 1577
  • [32] EFFECT OF PRIMING WITH DIPHTHERIA AND TETANUS TOXOIDS COMBINED WITH WHOLE-CELL PERTUSSIS-VACCINE OR WITH ACELLULAR PERTUSSIS-VACCINE ON THE SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF AN ACELLULAR PERTUSSIS-VACCINE CONTAINING A GENETICALLY INACTIVATED PERTUSSIS TOXIN IN 15-MONTH-OLD TO 21-MONTH-OLD CHILDREN
    PODDA, A
    BONA, G
    CANCIANI, G
    PISTILLI, AMC
    CONTU, B
    FURLAN, R
    MELONI, T
    STRAMARE, D
    TITONE, L
    RAPPUOLI, R
    GRANOFF, DM
    BARTALINI, M
    BUDRONI, M
    DELUCA, EC
    CASCIO, A
    CASCIO, G
    COSSU, M
    ORTO, PD
    DILEO, G
    DIPISA, F
    FURLAN, A
    MACAGNO, F
    MARSILI, I
    MAIDA, A
    MELONI, G
    MOIRAGHI, A
    NENCIONI, L
    PEPPOLONI, S
    REGOLI, D
    RIGO, G
    TRAPPAN, A
    UXA, F
    VARGIU, G
    VOLPINI, G
    JOURNAL OF PEDIATRICS, 1995, 127 (02): : 238 - 243
  • [33] Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis
    Giuliano, M
    Mastrantonio, P
    Giammanco, A
    Piscitelli, A
    Salmaso, S
    Wassilak, SGF
    JOURNAL OF PEDIATRICS, 1998, 132 (06): : 983 - 988
  • [34] An Efficacy Trial in Erlangen, Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP Vaccine (DTaP) or the Lederle Whole-Cell Component DTP Vaccine (DTP). • 714
    Ulrich Heininger
    James D. Cherry
    Klemens Stehr
    Suzanne Laussucq
    Rita Engelhardt
    Sabina Schmitt-Grohé
    Michael A. Überall
    Thomas Eckhardt
    Pediatric Research, 1997, 41 (Suppl 4) : 121 - 121
  • [35] Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines
    Ausiello, CM
    Urbani, F
    laSala, A
    Lande, R
    Cassone, A
    INFECTION AND IMMUNITY, 1997, 65 (06) : 2168 - 2174
  • [36] COMPARISON OF ACELLULAR (ACP) AND WHOLE CELL (WCP) PERTUSSIS VACCINES COMBINED WITH DIPHTHERIA (D)/TETANUS (T) TOXOIDS (DTACP VS DTWCP) FOR PRIMARY IMMUNIZATION IN INFANTS
    FELDMAN, S
    PERRY, S
    JONES, L
    MOFFITT, J
    CLINICAL RESEARCH, 1990, 38 (04): : A952 - A952
  • [37] Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
    Halperin, Scott A.
    Donovan, Catherine
    Marshall, Gary S.
    Pool, Vitali
    Decker, Michael D.
    Johnson, David R.
    Greenberg, David P.
    Bader, Gerald
    Weisman, Stuart
    Chauhan, Ambaram
    Bromberg, Kenneth
    McGuire, Michael
    Kabongo, Martin L.
    Hall, Matthew
    Weiner, Leonard
    Silas, Peter
    Brune, Daniel
    Craig, Tim
    Michaels, Marion
    Anderson, Edwin
    Keathley, Susan
    Rouse, Kevin
    Leader, Joseph
    Helman, Laura
    Andrews, Wilson
    Bernstein, David
    Middleton, Randall
    Ghosh, Mahashweta
    Mitchell, Douglas
    Senders, Shelly
    Wyszomierski, David
    Allison, David
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2019, 8 (02) : 105 - 114
  • [38] Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age
    Dagan, R
    Igbaria, K
    Piglansky, L
    Van Brusteghem, F
    Melot, V
    Kaufhold, A
    VACCINE, 1999, 17 (20-21) : 2620 - 2627
  • [39] STUDY OF PERTUSSIS VACCINES IN INFANTS - COMPARISON OF RESPONSE TO ACELLULAR PERTUSSIS DTP VACCINES CONTAINING 25 MU-G OF FHA AND EITHER 25 OR 8 MU-G OF PT WITH RESPONSE TO WHOLE-CELL PERTUSSIS DTP VACCINE
    VANURA, H
    JUST, M
    AMBROSCH, F
    BERGER, RM
    BOGAERTS, H
    WYNEN, J
    VANDEVOORDE, D
    WIEDERMANN, G
    VACCINE, 1994, 12 (03) : 210 - 214
  • [40] Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy-a prospective, observational cohort study from the United Kingdom
    Rice, T. F.
    Diavatopoulos, D. A.
    Smits, G. P.
    van Gageldonk, P. G. M.
    Berbers, G. A. M.
    van der Klis, F. R.
    Vamvakas, G.
    Donaldson, B.
    Bouqueau, M.
    Holder, B.
    Kampmann, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 197 (01): : 1 - 10